ACB
Price
$4.27
Change
+$0.17 (+4.15%)
Updated
Dec 20 closing price
46 days until earnings call
CRON
Price
$1.96
Change
+$0.09 (+4.81%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

ACB vs CRON

Header iconACB vs CRON Comparison
Open Charts ACB vs CRONBanner chart's image
Aurora Cannabis
Price$4.27
Change+$0.17 (+4.15%)
Volume$666.67K
CapitalizationN/A
Cronos Group
Price$1.96
Change+$0.09 (+4.81%)
Volume$28.69K
CapitalizationN/A
ACB vs CRON Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. CRON commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and CRON is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ACB: $4.27 vs. CRON: $1.95)
Brand notoriety: ACB: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 66% vs. CRON: 161%
Market capitalization -- ACB: $238.86M vs. CRON: $1B
ACB [@Pharmaceuticals: Other] is valued at $238.86M. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 5 TA indicator(s) are bullish while CRON’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 5 bullish, 4 bearish.
  • CRON’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than CRON.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -0.93% price change this week, while CRON (@Pharmaceuticals: Other) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

ACB is expected to report earnings on Feb 06, 2025.

CRON is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than ACB($239M). CRON YTD gains are higher at: -6.699 vs. ACB (-10.332). CRON has higher annual earnings (EBITDA): -71.8M vs. ACB (-1.64B). CRON has more cash in the bank: 862M vs. ACB (149M). CRON has less debt than ACB: CRON (2.55M) vs ACB (103M). ACB has higher revenues than CRON: ACB (212M) vs CRON (87.2M).
ACBCRONACB / CRON
Capitalization239M1.01B24%
EBITDA-1.64B-71.8M2,280%
Gain YTD-10.332-6.699154%
P/E RatioN/AN/A-
Revenue212M87.2M243%
Total Cash149M862M17%
Total Debt103M2.55M4,034%
FUNDAMENTALS RATINGS
ACB vs CRON: Fundamental Ratings
ACB
CRON
OUTLOOK RATING
1..100
7964
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9190
PRICE GROWTH RATING
1..100
6260
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (74) in the Pharmaceuticals Other industry is in the same range as ACB (96). This means that CRON’s stock grew similarly to ACB’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ACB (100). This means that CRON’s stock grew similarly to ACB’s over the last 12 months.

CRON's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as ACB (91). This means that CRON’s stock grew similarly to ACB’s over the last 12 months.

CRON's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as ACB (62). This means that CRON’s stock grew similarly to ACB’s over the last 12 months.

CRON's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ACB (100). This means that CRON’s stock grew significantly faster than ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBCRON
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 17 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VKSIX20.600.14
+0.68%
Virtus KAR Small-Mid Cap Core I
HSMBX36.630.19
+0.52%
Horizon Multi-Factor Small/Mid Cap Adv
PBSRX14.890.05
+0.34%
Polen US Small Company Growth Investor
BLDRX9.390.03
+0.32%
BlackRock Managed Income K
TIBGX25.280.05
+0.20%
Thornburg Investment Income Builder R4

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with TLRY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+4.28%
TLRY - CRON
73%
Closely correlated
+8.62%
SNDL - CRON
73%
Closely correlated
+4.05%
ACB - CRON
67%
Closely correlated
+4.15%
CGC - CRON
67%
Closely correlated
+4.43%
OGI - CRON
64%
Loosely correlated
+6.85%
More